A rare case of leiomyosarcoma arising from vault post-hysterectomy


  • Sonal Bhuyar Department of Obstetrics and Gynecology, Dr. PDMMC, Amravati, Maharashtra, India
  • Bhavana Sontakke Department of Obstetrics and Gynecology, Dr. PDMMC, Amravati, Maharashtra, India
  • Neha Dharmale Department of Obstetrics and Gynecology, Dr. PDMMC, Amravati, Maharashtra, India




Atypical leiomyomyoma, Leiomyosarcoma


Fibroid/Leiomyoma is the most common benign tumor of the uterus, arising from uterine smooth muscle. Atypical leiomyomas are rare forms of Myoma (fibroid uterus), of which recurrent atypical leiomyoma post hysterectomy is rarer and its converting in leiomyosarcoma arising from vault is rarest.  Here we report an unusual case of a 76yrs female, with leiomyosarcoma in an atypical leiomyoma arising from vault post-hysterectomy. A 76-year-old P3L3 patient presented with pain and distension of abdomen, post hysterectomy done 4 years back for chronic inversion and cervical fibroid polyp she was diagnosed as atypical leiomyoma. Laparotomy was done with a provisional diagnosis of leiomyosarcoma. Though Rarest (0.13-0.26%), a differential diagnosis of neoplastic changes should be kept in mind in patients with atypical leiomyoma, in patients presenting with any mass/pain abdomen, irrespective of any gynaecological complaints. This case shows that though it is unexpected after hysterectomy, leiomyosarcoma has to be considered in a case of abdominal mass. Atypical leiomyoma develops approximately in one to five cases out of 1,000 women with fibroid and it getting converted in leiomyosarcoma is rarest. Hence, diagnosis of leiomyosarcoma should always be kept in mind though the patient is hysterectomised.


Forney JP, Buschbaum HJ. Classifying staging and treating uterine sarcomas. Contemporary Ob Gyn. 1981;18(3):47-69.

Norris HJ, Zalouder CJ. Mesenchymal tumour of uterus. In: Blaustein A, eds. Pathology of female genital tract. 2nd edition. New York: Springer-Verlag Books; 1982:352-92.

Echt G, Jepson J, Steel J, Langholz B, Luxton G. Treatment of uterine sarcomas. Cancer. 1990;66:35-9.

Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol. 2002;20:2758-60.

Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasmam WT, Currie JL, et al. Prognostic factors in early stage uterine sarcoma. A Gynaecologic Oncology group study. Cancer. 1993;71(4):1702-9.

Evans HL, Chawla SP, Simpson C, Finn KP. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988;62(10):2239-47.

D’Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131-9.

Kempson RL. Sarcoma and related neoplasms. In: Norris HJ, Heritig AT, Abell MR, Eds. The uterus. Baltimore: Williams and Wilkins; 1973.

Pha SE, Byun JY, Jung SE. CT and MRI of uterine sarcoma and their mimickers. Am J Roentgenol. 2003;181:1369-74.

Piver MS, Lele SB, Marchetti DL, Emrich LJ. Effect of adjuvant chemotherapy on time to recurrence and survival of stage 1 uterine sarcomas. J Surg Oncol. 1988;38(4):233-9.






Case Reports